Cellular Engineering Technologies Inc

Cellular Engineering Technologies (CET) is a biotechnology company specializing in stem cell research, cancer biology and high throughput sensor fabrication. Our goal is to develop novel technologies to expedite drug discovery and screening processes. In addition, CET conducts translational research on non-embryonic stem cells with the ultimate goal of treating human disease. CET’s business focuses on three major themes: (1) stem cell research, (2) cancer biology, and (3) bioassay development and drug discovery using specialized high throughput sensors.

Recent products

Human Umbilical Vein Endothelial Cells

£295.00 / 413.00 Dry Shipper

HepG2 Human Hepatocellular Carcinoma Expansion Media

£49.00 / 68.60 Standard

HepG2 Human Hepatocellular Carcinoma Cells

£295.00 / 413.00 Dry Shipper

Lung Cancer Associated Fibroblast Expansion Media

£49.00 / 68.60 Standard

Mesenchymal Stem Cell Expansion Media

£45.00 / 63.00 Standard

Lung Cancer Tumor Samples

£895.00 / 1,253.00 Dry Shipper

Lung Cancer Associated Fibroblasts

£495.00 / 693.00 Dry Shipper

Cord Blood Multipotent Unrestricted Somatic Stem Cell Expansion Media

£65.00 / 91.00 Standard

Hematopoietic Stem Cell Expansion Media

£495.00 / 693.00 Standard

Neural Differentiation Media

£195.00 / 273.00 Standard

View all products from Cellular Engineering Technologies Inc